Market Trends of Netherlands Aesthetic Devices Industry
This section covers the major market trends shaping the Netherlands Aesthetic Devices Market according to our research experts:
Breast Implants Segment Expects to Register a Significant Growth Over the Forecast Period
The breast implant segment is expected to witness significant growth in the aesthetics devices market during the forecast period owing to the factors such as the rising prevalence of breast cancer among the population, increasing awareness about the beauty and physical appearance, and the availability of a variety of breast implants.
The rising burden of breast cancer in the country is the key factor driving the segment's growth. For instance, as per GLOBOCAN 2020 fact sheet, about 60,080 new breast cancer cases were reported in the country in 2020. Additionally, according to the DBIR Annual Report, about 47% of postoperative systemic antibiotics were administered more frequently for reconstructive procedures in the country in 2020. In addition, as per the same source, 66% of nipple guards were used for aesthetic procedures in 2020. Furthermore, 12,451 breast implant surgeries were conducted in the Netherlands in 2020, including 2,721 reconstructive surgeries after mastectomy for cancer, 535 reconstructive surgeries after prophylactic mastectomy, and 9,024 cosmetic augmentation procedures.
Furthermore, from the same source, 3,990 reconstructive procedures were reported in 2020 in the Netherlands. In addition, of these reconstructive surgeries, 1,760 (44%) were insertion-only procedures, 1,710 (43%) were replacement surgeries, and 520 (13%) were explantation-only procedures. Thus, the high number of aesthetic and cosmetic procedures performed in the country is expected to increase the demand for advanced aesthetic devices, propelling segment growth.
Therefore, owing to the factors such as the high burden of breast cancer and increasing breast implant surgeries, the segment studied is expected to grow over the forecast period.
Botulinum Toxin Segment is Expected to Have Significant Market Share Over the Forecast Period
The botulinum toxin segment is expected to witness significant growth in the aesthetics market in the Netherlands during the forecast period owing to factors such as the rise in demand for minimally invasive cosmetic methods and a higher number of beauty-conscious populations.
Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum. The injections of botulinum toxin tend to block the nerve signals to the muscle in which it is injected. When the muscle is not able to contract without a signal, it results in diminishing or decreasing unwanted facial wrinkles or appearance. As a result, highly diluted concentrations of botulinum toxin are used for cosmetic and non-cosmetic purposes, such as for the treatment of frown lines between the eyebrows, dystonia, chronic migraine, and other purposes. Some of the brands used in the Netherlands include Azzalure, Dysport, and Botox.
Additionally, the rising company activities in developing products, conducting clinical trials, and increasing product launches contribute to market growth. For instance, in April 2022, AbbVie conducted a Phase II clinical study to evaluate the efficacy and safety of botulinum toxin type A (AGN-151607) injections into the epicardial fat pads, foci of ganglionic plexi in patients.
Therefore, owing to the factors such as the rising demand and awareness for cosmetic procedures, the segment studied is expected to grow during the forecast period.
